Davis C, Elson E, Ning J, Swicord M
Authors not listed · 1992
FDA research shows ELF electromagnetic fields can alter cancer-related gene expression in human cells.
Plain English Summary
This FDA study examined how extremely low frequency (ELF) electromagnetic fields affect c-myc oncogene expression in both normal and cancer-transformed human cells. The c-myc gene plays a crucial role in cell growth and division, and its abnormal activation is linked to cancer development. The research found measurable effects on this cancer-related gene from ELF exposure.
Why This Matters
This research touches on one of the most concerning aspects of EMF exposure: its potential to influence genes directly involved in cancer development. The c-myc oncogene is particularly significant because it regulates cell proliferation and survival. When this gene becomes overactive, it can drive normal cells toward malignant transformation. What makes this study especially noteworthy is that it was conducted by FDA researchers, demonstrating that even government scientists have documented biological effects from ELF fields at the cellular level. The fact that both normal and transformed cells showed responses suggests these effects occur across different cell types. This research connects to everyday ELF exposure from power lines, household wiring, and electrical appliances, all of which generate the same type of extremely low frequency fields studied here.
Exposure Information
Specific exposure levels were not quantified in this study.
Show BibTeX
@article{davis_c_elson_e_ning_j_swicord_m_ce4007,
author = {Unknown},
title = {Davis C, Elson E, Ning J, Swicord M},
year = {1992},
doi = {10.1111/j.1749-6632.1992.tb49624.x},
}